Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev, vol.12, pp.1260-1268, 1998. ,
DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process, Bone, vol.40, pp.981-990, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00667539
Factor VIII-von Willebrand Factor complex inhibits osteoclastogenesis and controls cell survival, J Biol. Chem, vol.284, pp.31704-31713, 2009. ,
Role of osteoprotegerin (OPG) in cancer, Clin. Sci, vol.110, pp.279-291, 2006. ,
Osteoprotegerin in prostate cancer bone metastasis, Cancer Res, vol.65, pp.1710-1718, 2005. ,
Cytogenetics and molecular biology of osteosarcoma, Lab. Invest, vol.82, pp.365-373, 2002. ,
Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells, Biochem. Biophys. Res. Commun, vol.248, pp.696-700, 1998. ,
Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma, Cancer Res, vol.69, pp.526-536, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01680055
Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically, Cancer Res, vol.66, pp.3620-3628, 2006. ,
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells, Cancer Res, vol.62, pp.1619-1623, 2002. ,
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications, Int. J. Cancer, vol.111, pp.783-791, 2004. ,
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma, Clin. Chim. Acta, vol.379, pp.31-35, 2007. ,
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals, Cancer Metastasis Rev, vol.29, pp.405-434, 2010. ,
The Role of Osteoprotegerin and Tumor Necrosis Factor-related Apoptosis-inducing Ligand in Human Microvascular Endothelial Cell Survival, Mol. Biol. Cell, vol.15, pp.2834-2841, 2004. ,
Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colonyforming cells properties, J. Thromb. Haemost, vol.9, pp.834-843, 2011. ,
Homing and engraftment of progenitor cells: a prerequisite for cell therapy, J. Mol. Cell Cardiol, vol.45, pp.514-522, 2008. ,
The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization, ScientificWorldJournal, vol.10, pp.1088-1099, 2010. ,
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization, Curr. Pharm. Des, vol.16, pp.3903-3920, 2010. ,
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients, Clin. Breast Cancer, vol.11, pp.369-375, 2011. ,
Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells, Biochem. Pharmacol, vol.70, pp.1167-1175, 2005. ,
SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis, Mol. Cancer, vol.10, p.139, 2011. ,
On the role of Osteoprotegerin/RANK/RANKL system in the interaction between prostate cancer and bone, Digital comprehensive Summaries of Uppsala Dissertations, 2011. ,
Metastatic osteosarcoma causing intussusception, J. Pediatr. Surg, vol.38, pp.1-3, 2003. ,
Mechanistic study of the proangiogenic effect of osteoprotegerin, Angiogenesis, vol.16, pp.575-593, 2013. ,
Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis, Clin. Cancer Res, vol.18, pp.326-335, 2012. ,
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature, Clin. Exp. Metastasis, vol.28, pp.493-503, 2011. ,
The molecular pathogenesis of osteosarcoma: a review, Sarcoma, p.959248, 2011. ,
Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression, Clin. Cancer Res, vol.11, pp.490-497, 2005. ,
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis, Mod. Pathol, vol.19, pp.738-745, 2006. ,
Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma, Clin. Cancer Res, vol.16, pp.3769-3778, 2010. ,
Global gene expression profiling of human osteosarcomas reveals metastasisassociated chemokine pattern, Sarcoma, vol.2012, p.639038, 2012. ,
,
Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma, Virchows Archiv, vol.443, pp.146-151, 2003. ,
, Angiogenesis. Annu. Rev. Med, vol.57, pp.1-18, 2006.
Osteoprotegerin (OPG)-a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?, Int. J. Cancer, vol.118, pp.1901-1908, 2006. ,